A Phase I And Randomized Phase 2 Trial Of Epothilone B Analogue BMS 247550 (NSC 710428) [ixabepilone] Administered Every 21 Days With Or Without Oral Estramustine Phosphate In Patients With Androgen Independent Prostate Cancer

Trial Profile

A Phase I And Randomized Phase 2 Trial Of Epothilone B Analogue BMS 247550 (NSC 710428) [ixabepilone] Administered Every 21 Days With Or Without Oral Estramustine Phosphate In Patients With Androgen Independent Prostate Cancer

Completed
Phase of Trial: Phase I/II

Latest Information Update: 21 Jun 2013

At a glance

  • Drugs Ixabepilone (Primary) ; Estramustine
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top